The Use of Nanotechnology in Cancer Immunotherapy
American Journal Of Nano Science And Technology · 31.10.2023 · 4 (5) · 6-10
DOI: 10.71465/ajnst.1713 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Nano Science And Technology, online erschienen am 31.10.2023. Verfasst von Dr. Martina Elwood. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nanotechnology has emerged as a transformative tool in the landscape of cancer immunotherapy, offering novel strategies to enhance immune responses and target tumors more precisely. By employing engineered nanoparticles for antigen delivery, immune checkpoint inhibition, and microenvironment modulation, researchers are overcoming limitations associated with conventional immunotherapeutic approaches. This article explores the role of nanomaterials in augmenting both innate and adaptive immune functions while minimizing systemic toxicity. Advancements in nanoscale engineering have enabled the development of targeted delivery platforms and immune-modulatory nanocarriers, setting the stage for more effective and personalized cancer treatment paradigms.
Zitieren
APA
Elwood, D. M. (2023). The Use of Nanotechnology in Cancer Immunotherapy. American Journal Of Nano Science And Technology, 4(5), 6-10. https://doi.org/10.71465/ajnst.1713
Vancouver
Elwood DM. The Use of Nanotechnology in Cancer Immunotherapy. American Journal Of Nano Science And Technology. 2023;4(5):6-10. doi:10.71465/ajnst.1713
BibTeX
@article{Elwood2023,
author = {Elwood, Dr. Martina},
title = {The Use of Nanotechnology in Cancer Immunotherapy},
journal = {American Journal Of Nano Science And Technology},
year = {2023},
volume = {4},
number = {5},
pages = {6--10},
doi = {10.71465/ajnst.1713}
}
EUVIMED